|
|
|
Volumn 39, Issue 3, 2005, Pages 7-
|
|
FDA announces changes affecting the marketing of non-steroidal anti-inflammatory drugs.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
ISOXAZOLE DERIVATIVE;
LACTONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PYRAZOLE DERIVATIVE;
ROFECOXIB;
SULFONAMIDE;
SULFONE;
VALDECOXIB;
ARTICLE;
DRUG CONTROL;
DRUG LABELING;
LEGAL ASPECT;
MARKETING;
STANDARD;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DRUG AND NARCOTIC CONTROL;
DRUG LABELING;
ISOXAZOLES;
LACTONES;
MARKETING;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
|
|
EID: 24344486466
PISSN: 03621332
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|